Human papillomavirus genotype spectrum in Czech women: Correlation of HPV DNA presence with antibodies against HPV-16, 18, and 33 virus-like particles

Journal of Medical Virology

Volumn 58, Issue 4, 1999, Pages 378-386

  Tachezy, Ruth ^a   Hamsikova E ^a   Hajek T ^a   Mikyskova I ^a   Smahel M ^a   Van Ranst, M ^b   Kanka J ^c   Havrankova A ^c   Rob, L ^c   Guttner, V ^d   Slavik V ^c   Anton, M ^e   Kratochvil B ^c   Kotrsova L ^f   Vonka, V ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c CHARLES UNIVERSITY   (Czech Republic)

^d Medical Centre Prague   (Czech Republic)

^e MASARYK UNIVERSITY   (Czech Republic)

^f PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Cervical cancer; HPV genotype; PCR; Virus like particles

Indexed keywords

VIRUS ANTIBODY; VIRUS DNA;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; CZECH REPUBLIC; DISEASE SEVERITY; DOT HYBRIDIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; SEROPREVALENCE; UTERINE CERVIX CARCINOMA; UTERINE CERVIX TUMOR; VIRUS GENE; VIRUS INFECTION; WART VIRUS;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; TUMOR VIRUS;

EID: 0345643481     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199908)58:4<378::AID-JMV10>3.0.CO;2-P     Document Type: Article

References (40)

1. Bauer HM, Hildesheim A, Schiffman MH, Glass AG, Rush BB, Scott DR, Cadell DM, Kurman RJ, Manos MM. 1993. Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sex Transm Dis 20:274-278.
2. Bauer HM, Ting Y, Greer CE, Chambers JC, Tashiro CJ, Chimera J, Reingold A, Manos MM. 1991. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 265:472-477.
3. Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group. J Natl Cancer Inst 87:796-802.
4. Brinton LA. 1992. Epidemiology of cervical cancer. In: Muñoz N, Bosch FX, Shah KV, Meheus A, editors. The epidemiology of cervical cancer and human papillomavirus. Lyon, France: International Agency for Research on Cancer, p 3-23.
5. Carter JJ, Hagensee MB, Lee SK, McKnight B, Koutsky LA, Galloway DA. 1994. Use of HPV 1 capsids produced by recombinant vaccinia viruses in an ELISA to detect serum antibodies in people with foot warts. Virology 199:284-291.
6. Carter JJ, Hagensee M, Taflin MC, Lee SK, Koutsky LA, Galloway DA. 1993. HPV-1 capsids expressed in vitro detect human serum antibodies associated with foot warts. Virology 195:456-462.
7. Christensen ND, Hopfl R, DiAngelo SL, Cladel NM, Patrick SD, Welsh PA, Budgeon LR, Reed CA, Kreider JW. 1994. Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies. J Gen Virol 75:2271-2276.
8. Czegledy J, Gergely L, Hernadi Z, Poka R. 1989. Detection of human papillomavirus deoxyribonucleic acid in the female genital tract. Med Microbiol Immunol 178:309-314.
9. Czegledy J, Veress G, Konya J, Gergely L. 1993. Genital human papillomavirus (HPV) infection in Hungarian women. Acta Microbiol Hung 40:115-122.
10. de Villiers EM. 1997. Papillomavirus and HPV typing. Clin Dermatol 15:199-206.
11. Grce M, Husnjak K, Magdic L, Ilijas M, Zlacki M, Lepusic D, Lukac J, Hodek B, Grizelj V, Kurjak A, Kusic Z, Pavelic K. 1997. Detection and typing of human papillomaviruses by polymerase chain reaction in cervical scrapes of Croatian women with abnormal cytology. Eur J Epidemiol 13:645-651.
12. Hagensee ME, Galloway DA. 1993. Growing human papillomaviruses and virus like particles in the laboratory. Papillomavirus Rep 4: 121-122.
13. Hamšíková E, Ludvíková V, Šmahel M, Sapp M, Vonka V. 1998. Prevalence of antibodies to human papillomaviruses in the general population of the Czech Republic. Int J Cancer 77:689-694.
14. Hamšíková E, Šmahel M, Sapp M, Muñoz N, Bosch FX, Shah KV, Vonka V. 1997. Correlation between the presence of anti HPV33 VLP antibodies and HPV DNA in cervical neoplasia patients. Arch Virol 142:413-416.
15. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, Scott DR, Rush BB, Lawler P, Sherman ME, Kurman RJ, Manos MM. 1994. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 169:235-240.
16. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. 1995. Human papillomaviruses. In: IARC monographs on the evaluation of carcinogenic risks to humans. Lyon, France: International Agency for Research on Cancer.
17. Jacobs MV, Manos MM, Muñoz N, Bosch FX, Kummer A, Meijer CJLM, Shah KV, Snijders PJ, Walboomers JM. 1997. Prevalence of human papillomavirus in cervical cancer: extension of the worldwide IBSCC study. 16th International Papillomavirus Conference: Siena, Italy. p 455.
18. Kirnbauer R, Hubbert NL, Wheeler CM, Becker TM, Lowy DR, Schiller JT. 1994. A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J Natl Cancer Inst 86:494-499.
19. Kirnbauer R, Taub J, Greenstone HL, Roden R, Dürst M, Gissmann L, Lowy DR, Schiller JT. 1993. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J Virol 67:6929-6936.
20. Ley C, Bauer HM, Reingold A, Schiffman MH, Chambers JC, Tashiro CJ, Manos MM. 1991. Determinants of genital human papillomavirus infection in young women. J Natl Cancer Inst 83:997-1003.
21. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. 1992. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 79:328-337.
22. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. 1989. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 7:209-214.
23. Melkert PW, Hopman E, van den Brule AJ, Risse EK, van Diest PJ, Bleker OP, Helmerhorst T, Schipper ME, Meijer CJ, Walboomers JM. 1993. Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent. Int J Cancer 53:919-923.
24. Miller SA, Dykes DD, Polesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
25. Mincheva A, Shindarov L, Karageosov I, Slavchev B, Bachvarov D, Vasilev N, Makaveeva V. 1991. Detection of human papillomavirus DNA in gynaecological swabs by filter in situ hybridization. Acta Virol 35:209-217.
26. Nonnenmacher B, Hubbert NL, Kirnbauer R, Shah KV, Muńoz N, Bosch FX, de Sanjose S, Viscidi R, Lowy DR, Schiller JT. 1995. Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain. J Infect Dis 172:19-24.
27. Nonnenmacher B, Kruger KS, Svare EI, Scott JD, Hubbert NL, van den Brule AJ, Kirnbauer R, Walboomers JM, Lowy DR, Schiller JT. 1996. Seroreactivity to HPV16 virus-like particles as a marker for cervical cancer risk in high-risk populations. Int J Cancer 68: 704-709.
28. Parkin DM, Pisani P, Ferlay J. 1993. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54:594-606.
29. Rose RC, Bonnez W, Reichman RC, Garcea RL. 1993. Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of virus-like particles. J Virol 67:1936-1944.
30. Rose RC, Bonnez W, Strike DG, Reichman RC. 1990. Expression of the full-length products of the human papillomavirus type 6b (HPV-6b) and HPV-11 L2 open reading frames by recombinant baculovirus, and antigenic comparisons with HPV-11 whole virus particles. J Gen Virol 71:2725-2729.
31. Steele JC, Gallimore PH. 1990. Humoral assays of human sera to disrupted and nondisrupted epitopes of human papillomavirus type 1. Virology 174:388-398.
32. Tachezy R, Van Ranst M, Burk RD. 1994. Identification of novel human papillomavirus sequences by consensus primer mediated polymerase chain reaction. Biochem Biophys Res Commun 204: 820-827.
33. van den Brule AJ, Meijer CJ, Bakels V, Kenemans P, Walboomers JM. 1990. Rapid detection of human papillomavirus in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction. J Clin Microbiol 28:2739-2743.
34. van den Brule AJ, Walboomers JM, du Maine M, Kenemans P, Meijer CJLM. 1991. Difference in prevalence of human papillomavirus genotypes in cytomorphologically normal cervical smears is associated with a history of cervical intraepithelial neoplasia. Int J Cancer 48:404-408.
35. Van Ranst M, Kaplan JB, Burk RD. 1992. Phylogenetic classification of human papillomaviruses: correlation with clinical manifestations. J Gen Virol 73:2653-2660.
36. Veress G, Konya J, Csiky MT, Czegledy J, Gergely L. 1994. Human papillomavirus DNA and anti-HPV secretory IgA antibodies in cytologically normal cervical specimens. J Med Virol 43:201-207,
37. Volpers C, Schirmacher P, Streeck RE, Sapp M. 1994. Assembly of the major and the minor capsid protein of human papillomavirus type 33 into virus-like particles and tubular structures in insect cells. Virology 200:504-512.
38. Wideroff L, Schiffman MH, Nonnenmacher B, Hubbert N, Kirnbauer R, Greer CE, Lowy D, Lorincz AT, Manos MM, Glass AG. 1995. Evaluation of seroreactivity to human papillomavirus type 16 virus-like particles in an incident case-control study of cervical neoplasia. J Infect Dis 172:425-430.
39. zur Hausen H. 1991. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184:9-13.
40. zur Hausen H. 1996. Viruses in human tumors - reminiscences and perspectives. Adv Cancer Res 68:1-22.